In the present study, we included 8 eligible trials with 961 patients to estimate the test value of pentraxin 3 for respiratory tract infections and performed subgroup analyses to explore diagnostic accuracy for VAP and bacterial respiratory tract infections. The gene discussed is PTX3; the disease is ventilator-associated pneumonia.